Eradication of bacterial persisters with antibiotic-generated hydroxyl radicals

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 30, 2012, Pages 12147-12152

  Grant, Sarah Schmidt ^a,b,c   Kaufmann, Benjamin B ^a,c,d   Chand, Nikhilesh S ^d,e   Haseley, Nathan ^a,d,f   Hung, Deborah T ^a,b,c,d  

^a BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e HARVARD UNIVERSITY   (United States)

^f HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CLOFAZIMINE; DISSOLVED OXYGEN; HYDROXYL RADICAL; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE;

ANTIBIOTIC SENSITIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BACTERIAL INFECTION; CELL POPULATION; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; STOCHASTIC MODEL;

ANTI-BACTERIAL AGENTS; CLOFAZIMINE; DRUG RESISTANCE, BACTERIAL; GREEN FLUORESCENT PROTEINS; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; OXYGEN; REACTIVE OXYGEN SPECIES; THIOUREA; TUBERCULOSIS;

BACTERIA (MICROORGANISMS); MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS;

EID: 84864349736     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1203735109     Document Type: Article

References (49)

1. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC (1999) Consensus statement. Global burden of tuberculosis: Estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 282:677-686.
2. World Health Organization (2010) TB Fact Sheet (WHO, Geneva).
3. Sahbazian B, Weis SE (2005) Treatment of active tuberculosis: Challenges and prospects. Clin Chest Med 26:273-282, vi.
4. Espinal MA (2003) The global situation of MDR-TB. Tuberculosis 83:44-51. (Pubitemid 36686747)
5. Gomez JE, McKinney JD (2004) M. tuberculosis persistence, latency, and drug tolerance. Tuberculosis 84:29-44. (Pubitemid 38082931)
6. Warner DF, Mizrahi V (2006) Tuberculosis chemotherapy: The influence of bacillary stress and damage response pathways on drug efficacy. Clin Microbiol Rev 19:558-570. (Pubitemid 44134310)
7. Dhar N, McKinney J (2007) Microbial phenotypic heterogeneity and antibiotic tolerance. Tuberculosis 84:228-238.
8. McCune RM, Jr., Tompsett R (1956) Fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. I. The persistence of drug-susceptible tubercle bacilli in the tissues despite prolonged antimicrobial therapy. J Exp Med 104:737-762.
9. Jindani A, Doré CJ, Mitchison DA (2003) Bactericidal and sterilizing activities of antituberculosis drugs during the first 14 days. Am J Respir Crit Care Med 167:1348-1354. (Pubitemid 36609718)
10. Adams KN, et al. (2011) Drug tolerance in replicating mycobacteria mediated by a macrophage-induced efflux mechanism. Cell 145:1-15.
11. Ahmad Z, et al. (2009) Biphasic kill curve of isoniazid reveals the presence of drug-tolerant, not drug-resistant, Mycobacterium tuberculosis in the guinea pig. J Infect Dis 200:1136-1143.
12. Keren I, Minami S, Rubin E, Lewis K (2011) Characterization and transcriptome analysis of M. tuberculosis persisters. mBio 2:e00100-e00111.
13. Singh R, Barry CE, 3rd, Boshoff HI (2010) The three RelE homologs of Mycobacterium tuberculosis have individual, drug-specific effects on bacterial antibiotic tolerance. J Bacteriol 192:1279-1291.
14. Bigger JW (1944) Treatment of staphylococcal infections with penicillin. Lancet 244: 497-500.
15. Keren I, Shah D, Spoering A, Kaldalu N, Lewis K (2004) Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli. J Bacteriol 186:8172-8180. (Pubitemid 39603206)
16. Wood DN, Chaussee MA, Chaussee MS, Buttaro BA (2005) Persistence of Streptococcus pyogenes in stationary-phase cultures. J Bacteriol 187:3319-3328. (Pubitemid 40628685)
17. Lewis K (2006) Persister cells, dormancy and infectious disease. Nat Rev Microbiol.
18. Balaban NQ, Merrin J, Chait R, Kowalik L, Leibler S (2004) Bacterial persistence as a phenotypic switch. Science 305:1622-1625. (Pubitemid 39296357)
19. Lee HH, Molla MN, Cantor CR, Collins JJ (2010) Bacterial charity work leads to population-wide resistance. Nature 467:82-85.
20. Miller C, et al. (2004) SOS response induction by beta-lactams and bacterial defense against antibiotic lethality. Science 305:1629-1631. (Pubitemid 39296359)
21. Dörr T, Vulić M, Lewis K (2010) Ciprofloxacin causes persister formation by inducing the TisB toxin in Escherichia coli. PLoS Biol 8:e1000317.
22. Dörr T, Lewis K, Vulić M (2009) SOS response induces persistence to fluoroquinolones in Escherichia coli. PLoS Genet 5:e1000760.
23. Maisonneuve E, Shakespeare LJ, Jørgensen MG, Gerdes K (2011) Bacterial persistence by RNA endonucleases. Proc Natl Acad Sci USA 108:13206-13211.
24. Kohanski MA, Dwyer DJ, Hayete B, Lawrence CA, Collins JJ (2007) A common mechanism of cellular death induced by bactericidal antibiotics. Cell 130:797-810. (Pubitemid 47332566)
25. Dwyer DJ, Kohanski MA, Hayete B, Collins JJ (2007) Gyrase inhibitors induce an oxidative damage cellular death pathway in Escherichia coli. Mol Syst Biol 3:91.
26. Wang X, Zhao X (2009) Contribution of oxidative damage to antimicrobial lethality. Antimicrob Agents Chemother 53:1395-1402.
27. Kolodkin-Gal I, Sat B, Keshet A, Engelberg-Kulka H (2008) The communication factor EDF and the toxin-antitoxin module mazEF determine the mode of action of antibiotics. PLoS Biol 6:e319.
28. Nguyen D, et al. (2011) Active starvation responses mediate antibiotic tolerance in biofilms and nutrient-limited bacteria. Science 334:982-986.
29. Shatalin K, Shatalina E, Mironov A, Nudler E (2011) H2S: A universal defense against antibiotics in bacteria. Science 334:986-990.
30. Gusarov I, Shatalin K, Starodubtseva M, Nudler E (2009) Endogenous nitric oxide protects bacteria against a wide spectrum of antibiotics. Science 325:1380-1384.
31. United States Geological Survey Dotables. Available at http://water.usgs.gov/software/DOTABLES/.
32. Lewis K (2008) Multidrug tolerance of biofilms and persister cells. Curr Top Microbiol Immunol 322:107-131.
33. Herbert D, et al. (1996) Bactericidal action of ofloxacin, sulbactam-ampicillin, rifampin, and isoniazid on logarithmic- and stationary-phase cultures of Mycobacterium tuberculosis. Antimicrob Agents Chemother 40:2296-2299. (Pubitemid 26328035)
34. Wayne LG, Hayes LG (1996) An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence. Infect Immun 64:2062-2069. (Pubitemid 26165667)
35. Brook I (1989) Inoculum effect. Rev Infect Dis 11:361-368.
36. Imlay JA (2007) Cellular defenses against superoxide and hydrogen peroxide. Annu Rev Biochem 77:755-766.
37. Hassett DJ, Imlay JA (2007) Bactericidal antibiotics and oxidative stress: A radical proposal. ACS Chem Biol 2:708-710. (Pubitemid 350285904)
38. Yano T, et al. (2011) Reduction of clofazimine by mycobacterial type 2 NADH:quinone oxidoreductase: A pathway for the generation of bactericidal levels of reactive oxygen species. J Biol Chem 286:10276-10287.
39. Foti JJ, Devadoss B, Winkler JA, Collins JJ, Walker GC (2012) Oxidation of the guanine nucleotide pool underlies cell death by bactericidal antibiotics. Science 336:315-319.
40. Via LE, et al. (2008) Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates. Infect Immun 76:2333-2340.
41. West JB (1998) Respiratory Physiology (Williams & Wilkins, Baltimore), 5th Ed, p 62.
42. Kim JS, et al. (2011) Bacterial persisters tolerate antibiotics by not producing hydroxyl radicals. Biochem Biophys Res Commun 413:105-110.
43. Vega NM, Allison KR, Khalil AS, Collins JJ (2012) Signaling-mediated bacterial persister formation. Nat Chem Biol 8:431-433.
44. Allison KR, Brynildsen MP, Collins JJ (2011) Metabolite-enabled eradication of bacterial persisters by aminoglycosides. Nature 473:216-220.
45. Kim JS, et al. (2011) Selective killing of bacterial persisters by a single chemical compound without affecting normal antibiotic-sensitive cells. Antimicrob Agents Chemother 55:5380-5383.
46. Allison KR, Brynildsen MP, Collins JJ (2011) Heterogeneous bacterial persisters and engineering approaches to eliminate them. Curr Opin Microbiol 14:593-598.
47. Ehrt S, et al. (2005) Controlling gene expression in mycobacteria with anhydrotetracycline and Tet repressor. Nucleic Acids Res 33:e21.
48. Cochran WG (1950) Estimation of bacterial densities by means of the "most probable number". Biometrics 6:105-116.
49. Blodgett R (2010) Most probable number from serial dilutions. Bacteriological Analytical Manual. Available at http://www.fda.gov/Food/ ScienceResearch/LaboratoryMethods/BacteriologicalAnalyticalManualBAM/ucm109656. htm. Accessed June 26, 2012.